Profile data is unavailable for this security.
About the company
Jiangsu Recbio Technology Co Ltd is a China-based company mainly engaged in the research and development of vaccines. The Company has a portfolio of clinical-stage and pre-clinical stage vaccines, and its human papilloma virus (HPV) vaccine pipelines comprise of recombinant HPV 9-valent vaccine REC603, recombinant HPV 9-valent vaccines REC601 and REC602, recombinant HPV quadrivalent vaccine REC604a, and recombinant HPV 9-valent vaccine REC604b. The Company also involves in the development of Covid-19 vaccines. The Company mainly distributes products within domestic market.
- Revenue in HKD (TTM)0.00
- Net income in HKD-604.98m
- Incorporated2012
- Employees507.00
- LocationJiangsu Recbio Technology Co LtdNo. 888 Yaocheng AvenueChina Medical CityTAIZHOU ChinaCHN
- Phone+86 52 386818860
- Websitehttps://www.recbio.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Golden Throat Holdings Group Co Ltd | 1.11bn | 289.19m | 2.31bn | 860.00 | 8.00 | 1.64 | 6.97 | 2.09 | 0.3912 | 0.3912 | 1.50 | 1.91 | 0.4994 | 3.23 | 4.07 | 1,277,065.00 | 13.01 | 11.00 | 19.26 | 15.63 | 72.29 | 72.79 | 26.06 | 24.67 | 1.93 | 37.74 | 0.2814 | 83.15 | -3.09 | 6.73 | -11.04 | 19.61 | -32.13 | 38.94 |
| Ocumension Therapeutics | 342.22m | -355.93m | 3.22bn | 477.00 | -- | 1.07 | -- | 9.41 | -0.5431 | -0.5431 | 0.522 | 4.40 | 0.103 | 2.40 | 2.48 | 770,758.70 | -10.71 | -38.78 | -11.55 | -41.47 | 58.29 | 62.30 | -104.01 | -975.82 | 5.00 | -- | 0.0055 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
| Jiangsu Recbio Technology Co Ltd | 0.00 | -604.98m | 4.09bn | 507.00 | -- | 4.39 | -- | -- | -1.26 | -1.26 | 0.00 | 1.93 | 0.00 | -- | -- | 0.00 | -25.33 | -- | -32.84 | -- | -- | -- | -- | -- | 0.9619 | -60.96 | 0.4548 | -- | -- | -- | 20.86 | -- | -- | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -308.74m | 4.30bn | 148.00 | -- | 4.16 | -- | -- | -1.52 | -1.52 | 0.00 | 5.14 | 0.00 | -- | -- | 0.00 | -23.80 | -- | -25.44 | -- | -- | -- | -- | -- | 5.91 | -- | 0.0296 | -- | -- | -- | 65.62 | -- | -- | -- |
| Cutia Therapeutics | 219.31m | -578.29m | 4.44bn | 360.00 | -- | 3.39 | -- | 20.25 | -1.90 | -1.90 | 0.7205 | 4.31 | 0.1206 | 2.31 | 6.93 | 735,949.90 | -31.81 | -- | -35.82 | -- | 50.33 | -- | -263.68 | -- | 4.82 | -- | 0.1818 | -- | 1,110.83 | -- | -253.30 | -- | -- | -- |
| Shandong Boan Biotechnology Co Ltd | 793.90m | 68.17m | 4.90bn | 813.00 | 68.44 | 3.04 | 33.90 | 6.18 | 0.1337 | 0.1337 | 1.56 | 3.01 | 0.3069 | 1.10 | 2.60 | 976,501.30 | 2.63 | -- | 3.43 | -- | 74.10 | -- | 8.59 | -- | 1.03 | 4.01 | 0.3224 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
| Sihuan Pharmaceutical Holdings Group Ltd | 1.94bn | -41.69m | 5.03bn | 2.65k | -- | 1.03 | -- | 2.60 | -0.0045 | -0.0045 | 0.2085 | 0.5232 | 0.1506 | 0.9641 | 1.98 | 673,759.10 | -1.77 | -6.85 | -2.68 | -9.10 | 65.91 | 75.81 | -11.78 | -36.23 | 1.52 | -1.39 | 0.181 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
| AIM Vaccine Co Ltd | 1.31bn | -1.31bn | 5.16bn | 1.56k | -- | 1.34 | -- | 3.95 | -1.08 | -1.08 | 1.08 | 3.19 | 0.1462 | 0.6325 | 1.10 | 804,189.20 | -22.69 | -- | -37.16 | -- | 72.34 | -- | -155.22 | -- | 0.6836 | -6.61 | 0.3437 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
| Consun Pharmaceutical Group Ltd | 3.02bn | 922.45m | 5.23bn | 3.18k | 5.41 | 1.28 | 5.18 | 1.73 | 1.14 | 1.14 | 3.75 | 4.83 | 0.5209 | 2.00 | 11.77 | 966,028.20 | 15.97 | 12.04 | 23.24 | 19.25 | 74.22 | 74.55 | 30.66 | 24.89 | 2.80 | -- | 0.1144 | 40.84 | 10.71 | 7.03 | 14.88 | 11.01 | -22.93 | 18.43 |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 811.75m | 122.05m | 5.68bn | 948.00 | 15.45 | 0.7139 | -- | 6.99 | 0.1158 | 0.1158 | 0.7632 | 2.51 | 0.2504 | 1.26 | 1.35 | 856,278.10 | 3.75 | 7.03 | 4.66 | 9.05 | 91.25 | 92.17 | 14.97 | 17.26 | 3.78 | -- | 0.0052 | 39.16 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | -- |
Data as of Sep 20 2024. Currency figures normalised to Jiangsu Recbio Technology Co Ltd's reporting currency: Hong Kong Dollar HKD
3.57%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lake Bleu Capital (Hong Kong) Ltd.as of 20 Feb 2023 | 11.30m | 3.57% |
Data from 05 Jun 2024 - 05 Jun 2024Source: FactSet Research Systems Inc.
